Abstract
This study examines the interface between newborn screening and prenatal diagnosis from the point-of-view of parents of screen-positive children. Many conditions covered by newborn screening represent classic (autosomal recessive) Mendelian disorders. Parents of screen-positive infants therefore often come to learn that they are carriers of the disease, and face a decision whether to test for it in future pregnancies. Semi-structured interviews were conducted in 2015–2017 with 34 Israeli parents whose child was screen positive. Three major themes emanated from the parents’ attitudes toward prenatal testing for the disease in prospective hypothetical pregnancies: rejection of prenatal testing for the disease associated with the screen positive, and relying instead on newborn screening to reveal if a future baby is also sick (18/34, 53%); support of prenatal testing to get more information (7/34, 21%) and support of prenatal testing in order to abort in case of a test positive (9/34, 26%). We discuss the importance of newborn screening for reproductive decision-making, highlighting the arguments associated with positive and negative parental views of the possibility of having another child with the same condition associated with the screen-positive of the child that had already been born. The conclusions challenge the common assertion that parents pursue the dream of the “perfect child” through prenatal diagnosis that “naturally” leads to selective abortion. The diversity of views expressed by Israeli parents of screen-positive children highlights the diversity of normative scripts of “genetic responsibility” in the context of parenthood.
Similar content being viewed by others
Notes
Information retrieved from https://www.newbornscreening.info/Parents/otherdisorders/CAH.html, last accessed 4 July, 2017.
HCY, short for homocystinuria, is an amino acid disorder. Babies look healthy and normal at birth. Over time, if the condition is not treated, it can cause growth and learning delays. The milder form can be treated with vitamin B6 supplements. The other type does not respond to vitamin B6. Symptoms of both types vary widely from person to person. https://www.newbornscreening.info/Parents/aminoaciddisorders/CBS.html, accessed 14 July 2017
References
Arribas-Ayllon M, Sarangi S, Clarke A (2011) Genetic testing: accounts of autonomy, responsibility and blame. Routledge, London
Awiszus D, Unger I (1990) Coping with PKU: results of narrative interviews with parents. Eur J Pediatr 149(1):S45–S51
Blum LM (2015) Raising generation Rx: mothering kids with invisible disabilities in an age of inequality. New York University Press, New York
Bombard et al (2017) A secondary benefit: the reproductive impact of carrier results from newborn screening for cystic fibrosis. Genet Med 19(4):403–411
Brosco JP, Seider MI (2008) Adverse medical outcomes of early newborn screening programs for phenylketonuria. Pediatrics 122(1):192–197
Bryant L, Hewison JD, Green JM (2005) Attitudes towards prenatal diagnosis and termination in women who have a sibling with Down’s syndrome. J Reprod Infant Psychol 23(2):181–198
Buchbinder M, Timmermans S (2011) Medical technologies and the dream of the perfect newborn. Med Anthropol 30(1):56–80
Clancy T (2010) A clinical perspective on ethical arguments around prenatal diagnosis and preimplantation genetic diagnosis for later onset inherited cancer predispositions. Familial Cancer 9(1):9–14
Cohen BE, Szeinberg A, Peled I, Szeinberg B, Bar-Or R (1966) Screening program for early detection of phenylketonuria in the newborn in Israel. Isr J Med Sci 2(2):156–164
Crombag N et al (2014) Explaining variation in Down’s syndrome screening uptake: comparing the Netherlands with England and Denmark using documentary analysis and expert stakeholder interviews. BMC Health Serv Res 14:437. https://doi.org/10.1186/1472-6963-14-437
Davis TC et al (2006) Recommendations for effective newborn screening communication: results of focus groups with parents, providers, and experts. Paediatrics 117:326–340
Denzin NK, Lincoln Y (1994) Handbook of qualitative research. Sage, Thousand Oaks
Dudding T, Wilcken B, Burgess B, Hambly J, Turner G (2000) Reproductive decisions after neonatal screening identifies cystic fibrosis. Arch Dis Child Fetal Neonatal Ed 82(2):F124–F127
Duster T (2003) Backdoor to eugenics. Routledge, London
Ettore E (2000) Reproductive genetics, gender and the body: ‘please doctor, may I have a normal baby?’. Sociology 34:403–420
Ettore E (2002) Reproductive genetics, gender and the body. Routledge, London
Gammeltoft TM (2014) Haunting Images: A Cultural Account of Selective Reproduction in Vietnam. University of California Press, California
Gofin R, Adler B, Palti H (2004) Screening tests in prenatal care: a national study in Israel. Isr Med Assoc J 6:535–539
Grinshpun-Cohen J, Miron-Shatz T, Berkenstet M, Pras E (2015) The limited effect of information on Israeli pregnant women at advanced maternal age who decide to undergo amniocentesis. Israel J Health Policy Res 4:23. https://doi.org/10.1186/s13584-015-0019-6
Grob R (2006) Parenting in the genomic age: the ‘cursed blessing’ of newborn screening. New Genet Soc 25:159–170
Grob R (2008) Is my sick child healthy? Is my healthy child sick? Changing parental experiences of cystic fibrosis in the age of expanded newborn screening. Soc Sci Med 67:1056–1064
Gurian EA, Kinnamon DD, Henry JJ, Waisbren SE (2006) Expanded newborn screening for biochemical disorders: the effect of a false-positive result. Pediatrics 117:1915–1921
Hashiloni-Dolev Y (2007) A life (un)worthy of living: reproductive genetics in Israel and Germany. Springer- Kluwer, Berlin
Hayeems RZ, Bytautas JP, Miller FA (2008) A systematic review of the effects of disclosing carrier results generated through newborn screening. J Genet Couns 17(6):538–549
Juengst E (1995) “Prevention” and the goals of genetic medicine. Hum Gene Ther 6:1595–1605
Kelly S (2009) Choosing not to choose: reproductive responses of parents of children with genetic conditions or impairments. Sociol Health Illness 31(1):81–97
Kerr SM, McIntosh JB (2000) Coping when a child has a disability: exploring the impact of parent-to-parent support. Child Care Health Dev 26:309–322
Landsman G (2009) Reconstructing motherhood and disability in an age of “perfect” babies. Routledge, London
Leib JR, Gollust SE, Hull SC, Wilfond BS (2005) Carrier screening panels for Ashkenazi Jews: is more better? Genet Med 7(3):185–190
Lemke T (2007) Susceptible individuals and risky rights: dimensions of genetic responsibility. In: Dumit J, Burri V (eds) Biomedicine as culture. Instrumental practices, technoscientific knowledge, and new modes of life. Routledge, London
Lewis S, Curnow L, Ross M, Massie J (2006) Parental attitudes to the identification of their infants as carriers of cystic fibrosis by newborn screening. J Paediatr Child Health 42(9):533–537
Markens S, Browner CH, Press N (1999) ‘Because of the risks’: how US pregnant women account for refusing prenatal screening. Soc Sci Med 49:359–369
Mischler EH, Wilfond BS, Fost N, Laxova A, Reiser C, Sauer CM, Makholm LM, Shen G, Feenan L, McCarthy C, Farrell PM (1998) Cystic fibrosis screening: impact on reproductive behaviour and implications for genetic counselling. Pediatrics 102:44–52
Mor S (2005) Between charity, welfare, and warfare: a disability legal studies analysis of privilege and neglect in Israeli disability policy. Yale J Law Humanit 18(63):63–136
Moyer V et al (2008) Expanding newborn screening: process, policy, and priorities. Hastings Cent Rep 38(3):32–39
Natoli JL, Ackerman DL, McDermott S, Edwards JG (2012) Prenatal diagnosis of down syndrome: a systematic review of termination rates (1995-2011). Prenat Diagn 32(2):142–153
Natowicz M (2005) Newborn screening - setting evidence-based policy for protection. N Engl J Med 353(9):867–870
Novas C, Rose N (2000) Genetic risk and the birth of the somatic individual. Econ Soc 29:485–513
Parens E, Asch A (eds) (2000) Prenatal testing and disability rights. Georgetown University Press, Washington, D.C.
Paul D (2008) Patient advocacy in newborn screening: continuities and discontinuities. Am J Med Genet Part C 148C:8–14
Polizzi A, Carbone P, Taruscio D (2013) Expanded newborn screening: a chess board motif in public health. J Pediatr Biochem 6(1):66–70
Press NA, Browner CH (1993) “Collective fictions”: similarities in reasons for accepting maternal serum alpha-fetoprotein screening among women of diverse ethnic and social class backgrounds. Fetal Diagn Ther 8(1):97–106
Rapp R (1998) Refusing prenatal diagnosis: the meanings of bioscience in a multicultural world. Sci Technol Hum Values 23(1):45–70
Rapp R (1999) Testing women, testing the fetus: the social impact of amniocentesis in America. Routledge, New York
Raspberry K, Skinner D (2011a) Enacting genetic responsibility: experiences of mothers who carry the fragile X gene. Sociol Health Illness 33(3):420–433
Raspberry K, Skinner D (2011b) Negotiating desires and options: how mothers who carry the fragile X gene experience reproductive decisions. Soc Sci Med 72:992–998
Raz A (2004) “Important to test, important to support”: attitudes toward disability rights and prenatal diagnosis among leaders of support groups for genetic disorders in Israel. Soc Sci Med 59(9):1857–1866
Raz A (2009a) Community Genetics and Genetic Alliances: Eugenics, Carrier Testing, and Networks of Risk. New York and. Routledge, London
Raz A (2009b) Eugenic utopias/dystopias, reprogenetics, and community genetics. Sociol Health Illness 31:602–616
Raz A and Timmermans S (2017) Divergent evolution of newborn screening: Israel and the US as gene worlds. BioSocieties (accepted for publication)
Remennick L (2006) The quest for a perfect baby: why do Israeli women seek prenatal genetic testing? Sociol Health Illness 28(1):21–53
Rimmerman A, Soffer M, David D, Dagan T, Rothler R, Mishaly L (2015) Mapping the terrain of disability legislation: the case of Israel. Disabil Soc 30(1):46–58
Rimon-Zarfaty, N. & A. Raz 2010. Abortion Committees as Agents of Eugenics: Medical and Public Views on Selective Abortion following Mild or Likely Embryopathy. Chapter 9 In: Birenbaum-Carmeli, Daphna and Carmeli, Yoram (Eds.), Kin, Gene, Community: Reproductive Technologies among Jewish Israelis. Oxford: Berghahn Press
Risøy S, Sirnes T (2015) The decision: relations to oneself, authority and vulnerability in the field of selective abortion. BioSocieties 10(3):317–340
Rose N (2006) The politics of life itself: biomedicine, power, and subjectivity in the twenty-first century. Princeton University Press, Princeton
Rothschild J (2005) The dream of the perfect child. Indiana University Press, Bloomington
Sawyer S et al (2006) Changing their minds with time: a comparison of hypothetical and actual reproductive behaviors in parents of children with cystic fibrosis. Pediatrics 118(3):649–659
Shapira A (1995) Wrongful life. In: Suits by defective newborns for faulty genetic counseling, in the human genome project: legal, social and ethical implications—proceedings of an international workshop. Israel Academy of Sciences and Humanities, Jerusalem
Shilling V, Morris C, Thompson-Coon J, Ukoumunne O, Rogers M, Logan S (2013) Peer support for parents of children with chronic disabling conditions: a systematic review of quantitative and qualitative studies. Dev Med Child Neurol 55:602–609
Soffer M, Rimmerman A, Blanck P, Hill E (2010) Media and the Israeli disability rights legislation. Disabil Soc 25(6):687–699
Stafler P, Mei-Zahav M, Wilschanski M, Mussaffi H, Efrati O, Lavie M, Shoseyov D, Cohen-Cymberknoh M, Gur M, Bentur L, Livnat G, Aviram M, Alkrinawi S, Picard E, Prais D, Steuer G, Inbar O, Kerem E, Blau H (2016) The impact of a national population carrier screening program on cystic fibrosis birth rate and age at diagnosis: implications for newborn screening. J Cyst Fibros 15:460–466
Steinbach RJ, Allyse M, Michie M, Liu EY, Cho MK (2016) This lifetime commitment: public conceptions of disability and noninvasive prenatal genetic screening. Am J Med Genet A 170A(2):363–374
Strauss A, Corbin J (1990) Basics of qualitative research. Grounded theory procedures and techniques. Sage, Newbury Park
The Knesset Research and Information Center (2003) Background paper on selective abortions. Jerusalem (in Hebrew)
Timmermans S, Buchbinder M (2010) Patients-in-waiting: living between sickness and health in the genomics era. J Health Soc Behav 51(4):408–423
Timmermans S, Buchbinder M (2013) Saving babies? The consequences of newborn genetic screening. University of Chicago Press, Chicago
Timmermans S, Shostak S (2016) Gene worlds. Health 20(1):33–48
Timmermans S, Tavory I (2007) Advancing ethnographic research through grounded theory practice. In: Bryant, Charmaz K (eds) Handbook of Grounded Theory. Sage, London, pp 493–513
Vailly J (2008) The expansion of abnormality and the biomedical norm: neonatal screening, prenatal diagnosis and cystic fibrosis in France. Soc Sci Med 66(12):2532–2543
Ville I, Mirlesse V (2015) Prenatal diagnosis: from policy to practice. Two distinct ways of managing prognostic uncertainty and anticipating disability in Brazil and in France. Soc Sci Med 141:19–26
Wertz DC, Janes SR, Rosenfield JM, Erbe RW (1992) 1992. Attitudes toward the prenatal diagnosis of cystic fibrosis: factors in decision making among affected families. Am J Hum Genet 50:1077–1085
Wieser B (2010) Public accountability of newborn screening: collective knowing and deciding. Soc Sci Med 70:926–933. https://doi.org/10.1016/j.socscimed.2009.12.001
Zlotogora J, Israeli A (2009) A comprehensive screening program for cystic fibrosis. Isr Med Assoc J 11(9):555–557
Zlotogora J, Haklai Z, Leventhal A (2007) Utilization of prenatal diagnosis and termination of pregnancies for the prevention of down syndrome in Israel. Isr Med Assoc J 9(8):600–602
Zlotogora J, Grotto I, Kaliner E, Gamzu R (2016) The Israeli national population program of genetic carrier screening for reproductive purposes. Genet Med 18(2):203–206
Zuckerman, S. 2009. The expansion of newborn screening in Israel: ethical dimensions. PhD Dissertation, Case Western Reserve University
Zuckerman S (2017) Indifferent or uninformed? Reflections of health professionals on parental education and consent for expanded newborn screening in Israel, 2008–2016. Int J Neonatal Screening 3:12. https://doi.org/10.3390/ijns3020012
Funding
This study was funded by the USA–Israel Binational Science Foundation Award Number: 2012109.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000 (5). Informed consent was obtained from all patients for being included in the study.
Conflict of interest
The authors declare that they have no conflict of interests.
Rights and permissions
About this article
Cite this article
Raz, A.E., Amano, Y. & Timmermans, S. Coming to terms with the imperfectly normal child: attitudes of Israeli parents of screen-positive infants regarding subsequent prenatal diagnosis. J Community Genet 10, 41–50 (2019). https://doi.org/10.1007/s12687-018-0361-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12687-018-0361-9